Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Evogene Ltd Ord (NQ: EVGN )

2.690 -0.050 (-1.82%)
Streaming Delayed Price Updated: 3:59 PM EDT, Sep 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 13,414
Open 2.780
Bid (Size) 2.640 (2)
Ask (Size) 2.710 (1)
Prev. Close 2.740
Today's Range 2.610 - 2.780
52wk Range 2.610 - 10.40
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
EVGN Stock Earnings: Evogene Misses EPS, Beats Revenue for Q2 2024
EVGN stock results show that Evogene missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
EVGN Stock Earnings: Evogene Beats EPS, Beats Revenue for Q1 2024
EVGN stock results show that Evogene beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace

Performance

YTD
-69.12%
-69.12%
1 Month
-33.58%
-33.58%
3 Month
-56.27%
-56.27%
6 Month
-65.73%
-65.73%
1 Year
-60.44%
-60.44%

More News

Read More
EVGN Stock Earnings: Evogene Beats EPS, Misses Revenue for Q4 2023
Via InvestorPlace
Israeli Company Reports Record 2023 Revenue, Wants To Transition Cannabis Operations To 'Third Party'
Via Benzinga
Topics Cannabis
Exposures Cannabis
Israeli Cannabis Company Reports Strong Q3 Despite Geopolitical Challenges
Via Benzinga
Topics Cannabis
Exposures Cannabis
Recap: Evogene Q3 Earnings
Via Benzinga
A Preview Of Evogene's Earnings
Via Benzinga
Lake Street Maintains Buy Rating for Evogene: Here's What You Need To Know
Via Benzinga
Earnings Outlook For Evogene
Via Benzinga
Earnings Scheduled For March 7, 2024
Via Benzinga
Evogene Earnings Preview
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 2, 2023
Via Benzinga
Why Evogene Shares Are Moving
Via Benzinga
Israeli Cannabis Co. Reports Solid Q2 Performance, Nearing Growth Targets
Via Benzinga
Topics Cannabis
Exposures Cannabis
Why Evogene Stock Is Tanking Today
Via Benzinga
Evogene's Casterra Gets $2.2M Orders To Supply Castor Seeds
Via Benzinga
TalkMarkets Announces Company Spotlight Featuring Evogene
Via Talk Markets
Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why Aehr Test Systems Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Via Benzinga
TalkMarkets Announces Company Spotlight Featuring Evogene
Via TheNewswire.com
TalkMarkets Announces Company Spotlight Featuring Evogene
Via News Direct
Evogene - A Company With Valuable Assets Trading At Zero Enterprise Value
Via Talk Markets
Why ToughBuilt Industries Shares Are Trading Lower By Over 46%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Why Evogene (EVGN) Stock Is Trading Higher
Via Benzinga
Tryp Submits IND Application To FDA For Clinical Trial Of Psilocybin-Assisted Psychotherapy In Patients With IBS
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.